… In particular, we expect that the scientific criteria for what constitutes a biosimilar product
will … 14 For a recent survey of this literature and an updated analysis, see A. Saha et al., “Generic …

… during the review period that are of a technical nature and relate to topics such as the
physicochemical and pharmacological characterisation of potential biosimilar medicines. …

… After this literature review process, 19 papers were selected (Figure 2). … per the literature
review, is more frequently associated with a worse prognostic characterized by hemodynamic …

… Finally, biosimilars are already being marketed in some countries, … A systematic review of
systematic reviews showed that visual … Data from a long-term post hoc analysis showed that the …

… In contrast, the regulatory review of biosimilars is far more focused on molecular … The concept
of biosimilars: from characterization to evolution — a narrative review. Oncologist 2018; 23: …

… According to a systematic literature review based on 90 published studies, the great … ,
safety or efficacy when patients switched to biosimilars. Three large studies did not show …

… understanding of the regional biosimilar market. Despite the challenges posed by this, the
commercial potential of the biosimilar … For the literature review, information from primary and …

… and their biosimilars, and the cost savings generated by the introduction of biosimilars in
French hospitals 5 years ago. … The concept of biosimilars: from characterization to evolution – a …

… In the present analysis, we compared the continuation rates of patients with RA who were
newly started on either ETNRP or LBEC0101 and no significant differences were observed (…

… on product characteristics into account. This requires a set of state-of-the-art analytical
methods capable of characterizing the original and the biosimilar product in detail. Biosimilars to …